[250 Pages Report] The home sleep apnea testing market is likely to register a CAGR of 14.4% during the forecast period, and is anticipated to reach a market share of US$ 3.09 Bn in 2032, from US$ 0.70 Bn in 2021, owing to the increasing prevalence of sleep apnea throughout the globe.
| Attributes | Details |
|---|---|
| Home Sleep Apnea Testing Market CAGR | 14.4% |
| Home Sleep Apnea Testing Market Size (2020) | US$ 0.70 Bn |
| Home Sleep Apnea Testing Market Size (2032) | US$ 3.09 Bn |
Demand for home sleep apnea testing is thriving, as more than 45 million people in the United States suffered from chronic and long-term sleep disorders in 2017, according to the National Commission on Sleep Disorder Research.
Regulations from regional regulatory bodies for the manufacturing of sleep apnea devices have recently made the sales of home sleep apnea testing become stiffer, which may provide a barrier for new home sleep apnea testing manufacturers.
Furthermore, demand for home sleep apnea testing is high, as it provides a wide range of information to the physician concerning the patient's breathing pattern. Various home sleep apnea testing devices, as well as well-equipped sensors and detectors, are available on the market, boosting the sales of home sleep apnea testing.
These sleep apnea diagnostic equipment frequently includes heart rate and oxygen capacity measurements. Due to its various applications, sales of home sleep apnea testing are expanding. Usually, home sleep apnea testing devices are capable of diagnosing obstructive sleep apnea, contributing to the home sleep apnea testing market share.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The demand for home sleep apnea testing has increased due to an increase in the number of patients suffering from obesity and chronic sinusitis. As a result, the rising prevalence of sleep apnea around the world has increased the sales of home sleep apnea testing in the recent decade.
In addition, home sleep apnea testing is a low-cost and simple way to identify sleep apnea. The cost-effectiveness of sleep apnea testing is a major driving force behind its rapid expansion of the home sleep apnea testing market.
Furthermore, favorable reimbursement policies and coverage by private insurance service providers are likely to drive revenue growth by increasing the global sales of home sleep apnea testing.
Furthermore, the increased focus of modern fitness centers, rehabilitation centers, and yoga centers on educating people about sleep apnea would contribute to the growth of the home sleep apnea testing market share.
The results of home sleep apnea testing devices are not always reliable and can result in misleading measurements, which may limit the demand for home sleep apnea testing devices throughout the projection period.
Due to the demand for home sleep apnea testing among the general public, North America, Europe, and the Asia Pacific area are likely to have the strongest development potential. North America is the leading region in terms of home sleep apnea testing market share, followed by Europe.
Due to the availability of advantageous reimbursement scenarios, European nations such as the United Kingdom, Germany, and France are expected to provide the largest revenue share due to global sales of home sleep apnea testing devices.
As a result, Europe has become a center for manufacturers of home sleep apnea testing devices. The rise in the number of people suffering from sleep apnea, particularly in India and China, has fueled the sales of home sleep apnea testing devices.
Principal Consultant
NovaSom, Curative Medical Inc, Resmed, Sleep Med Inc, and Phillips Respironics, among others, are some of the leading participants in the value chain home sleep apnea testing market, holding a substantial home sleep apnea testing market share.
| Report Attribute | Details |
|---|---|
| Growth rate | CAGR of 14.4% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 - 2020 |
| Forecast period | 2022 - 2032 |
| Quantitative units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis |
| Segments covered | Product type, home technology, region |
| Regional scope | North America; Western Europe, Eastern Europe, Middle East, Africa, ASEAN, South Asia, Rest of Asia, Australia and New Zealand |
| Country scope | U.S.; Canada; Mexico; Germany; U.K.; France; Italy; Spain; Russia; Belgium; Poland; Czech Republic; China; India; Japan; Australia; Brazil; Argentina; Colombia; Saudi Arabia; UAE; Iran; South Africa |
| Key companies profiled | NovaSom, Curative Medical Inc, Resmed, Sleep Med Inc, and Phillips Respironics, among others |
| Customization scope | Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The home sleep apnea testing market is anticipated to register a CAGR of 14.4% during the forecast period.
The home sleep apnea testing market share is anticipated to reach US$ 3.09 Bn in 2032.
Demand for home sleep apnea testing is likely to rise, owing to the increasing prevalence of sleep apnea throughout the globe.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Home Sleep Apnea Testing Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Home Sleep Apnea Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Product Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Product Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Product Type, 2022-2032
5.3.1. CPAP Devices
5.3.2. BPAP Devices
5.3.3. Adaptive Servo-Ventilation (ASV) Devices
5.3.4. Mandibular Advancement Devices
5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Product Type, 2022-2032
Deep-dive segmentation will be available in the sample on request
6. Global Home Sleep Apnea Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Indication
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Indication, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Indication, 2022-2032
6.3.1. Obstructive Sleep Apnea
6.3.2. Insomnia
6.3.3. Cognitive Impairment
6.3.4. Daytime Sleepiness
6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021
6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032
Deep-dive segmentation will be available in the sample on request
7. Global Home Sleep Apnea Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia & Pacific
7.3.6. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Home Sleep Apnea Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Product Type
8.2.3. By Indication
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Product Type
8.3.3. By Indication
8.4. Key Takeaways
9. Latin America Home Sleep Apnea Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Mexico
9.2.1.2. Brazil
9.2.1.3. Rest of Latin America
9.2.2. By Product Type
9.2.3. By Indication
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product Type
9.3.3. By Indication
9.4. Key Takeaways
10. Europe Home Sleep Apnea Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. U.K.
10.2.1.5. Spain
10.2.1.6. BENELUX
10.2.1.7. Russia
10.2.1.8. Rest of Europe
10.2.2. By Product Type
10.2.3. By Indication
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product Type
10.3.3. By Indication
10.4. Key Takeaways
11. East Asia Home Sleep Apnea Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.2. By Product Type
11.2.3. By Indication
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product Type
11.3.3. By Indication
11.4. Key Takeaways
12. South Asia & Pacific Home Sleep Apnea Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. ASEAN
12.2.1.3. Australia and New Zealand
12.2.1.4. Rest of South Asia & Pacific
12.2.2. By Product Type
12.2.3. By Indication
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product Type
12.3.3. By Indication
12.4. Key Takeaways
13. MEA Home Sleep Apnea Testing Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. Turkey
13.2.1.3. South Africa
13.2.1.4. Rest of MEA
13.2.2. By Product Type
13.2.3. By Indication
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product Type
13.3.3. By Indication
13.4. Key Takeaways
14. Key Countries Home Sleep Apnea Testing Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Product Type
14.1.2.2. By Indication
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Product Type
14.2.2.2. By Indication
14.3. Mexico
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Product Type
14.3.2.2. By Indication
14.4. Brazil
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Product Type
14.4.2.2. By Indication
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Product Type
14.5.2.2. By Indication
14.6. Italy
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Product Type
14.6.2.2. By Indication
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Product Type
14.7.2.2. By Indication
14.8. U.K.
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Product Type
14.8.2.2. By Indication
14.9. Spain
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Product Type
14.9.2.2. By Indication
14.10. BENELUX
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Product Type
14.10.2.2. By Indication
14.11. Russia
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Product Type
14.11.2.2. By Indication
14.12. China
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Product Type
14.12.2.2. By Indication
14.13. Japan
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Product Type
14.13.2.2. By Indication
14.14. South Korea
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Product Type
14.14.2.2. By Indication
14.15. India
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Product Type
14.15.2.2. By Indication
14.16. ASEAN
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Product Type
14.16.2.2. By Indication
14.17. Australia and New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Product Type
14.17.2.2. By Indication
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Product Type
14.18.2.2. By Indication
14.19. Turkey
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Product Type
14.19.2.2. By Indication
14.20. South Africa
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2021
14.20.2.1. By Product Type
14.20.2.2. By Indication
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product Type
15.3.3. By Indication
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Resmed
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Koninklijke Philips
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Fisher & Paykel Healthcare
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Somnomed
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Oventus Medical
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Compumedics
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Löwenstein Medical
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. Drive Devilbiss Healthcare
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. BMC Medical
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Home Sleep Apnea Testing Market
